| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9261570 | Autoimmunity Reviews | 2005 | 6 Pages |
Abstract
We have introduced substantial modifications in SEREX, designed to minimize confounding effects of unrelated autoantibodies and to eliminate steps that preclude the identification of cancer-related autoantigens commonly recognized by cancer sera. In addition, we incorporate methodology to identify candidate antigens that have potential diagnostic or prognostic value prior to their molecular cloning and characterization.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Félix Fernández Madrid, Naimei Tang, Huda Alansari, Robert L. Karvonen, John E. Tomkiel,